Forum Network

Jeffrey A. Coderre is Associate Professor of Nuclear Engineering.

Alan Jasanoff is an Associate Member of the McGovern Institute for Brain Research, and an Associate Professor with a primary appointment in the Department of Biological Engineering and additional appointments with the Departments of Brain and Cognitive Sciences, Nuclear Science, and Engineering. Prior to joining the MIT faculty in 2004, he was a Whitehead Fellow at the Whitehead Institute for Biomedical Research at MIT. He received a Ph.D. in biophysics in 1998 from Harvard in the laboratory of Don Wiley, where he was supported by a Howard Hughes Medical Institute pre-doctoral fellowship. He also earned an M.Phil. in Chemistry at Cambridge University in 1993 and an undergraduate degree in biochemistry from Harvard College in 1992. He was named a Raymond and Beverly Sackler Foundation Scholar in 2004, and he received a 2006 McKnight Technological Innovations in Neuroscience Award for developing methods to apply MRI calcium sensors for cellular-level functional imaging in living animals.

Dwight L. Williams, a Martin Luther King Visiting Professor, holds a dual appointment in the Security Studies Program and the Department of Nuclear Science and Engineering. He earned his Ph.D. in nuclear engineering from the University of Maryland. His dissertation addressed scientific mechanisms required to effectively validate the Comprehensive Test Ban Treaty (CTBT). He spent four year at the international CTBT personnel training and data processing headquarters, where he instructed international scientists prior to their service at the United Nations facility in Vienna, Austria. Afterwards, he began working for the Defense Intelligence Agency where he continues to work today. As Principal Nuclear Physicist in the Weapons Intelligence Office, he is actively involved in defense, intelligence community (IC), and research and development activities. He is working with the White House on a national nuclear research strategy and regularly briefs members of Congress. In 2006, he won a Director of National Intelligence Fellow Award. This is the highest IC award available to scientists and was conferred at a White House ceremony. Other awards include a Certificate of Congressional Recognition and countless commendations for accomplishments in support of the U.S. led war on terrorism and federal technical research.

Allison Macfarlane is currently an Associate Professor of Environment Science and Policy at George Mason University and an associate of the Belfer Center for Science and International Affairs' Project on Managing the Atom at Harvard University. She was formerly an MTA/ISP postdoctoral fellow. She was most recently a Research Associate at MIT's Program in Science, Technology, and Society. Previously, she was Associate Professor of International Affairs and Earth & Atmospheric Science at Georgia Tech. She received her PhD in geology from MIT in 1992. She has held the position of professor of geology and women's studies at George Mason University. She has also held fellowships at the Bunting Institute at Radcliffe College, the Center for International Security and Arms Control at Stanford University, and the Belfer Center for Science and International Affairs at Harvard University. From 1998 to 2000 she was a Social Science Research Council MacArthur Foundation fellow in International Peace and Security. From 1999 to 2001 she served on a National Academy of Sciences panel on the spent fuel standard and excess weapons plutonium disposition. Her research focuses on international security and environmental policy issues associated with nuclear weapons and nuclear energy. Her book on the unresolved technical issues for nuclear waste disposal at Yucca Mountain, Nevada, *Uncertainty Underground*, was published in 2006.

Dr. Andrew C. Kadak is a Professor of the Practice in the MIT Department of Nuclear Engineering. Dr. Kadak was the faculty advisor to the MIT Mars Nuclear Power Team convened jointly between the MIT Nuclear Engineering and Aeronautics & Astronautics Departments in the Spring of 2003. The team performed an extensive design study of requirements for nuclear power systems to support round-trip human missions to Mars, and provided recommendations for future development in this area. Dr. Kadak has spent his entire career in the nuclear energy field. He graduated from Union College in 1967 and received his masters and doctorate degrees in Nuclear Engineering from Massachusetts Institute of Technology. He also received a masters degree in Business Administration from Northeastern University in 1983. He was formerly the President and CEO of Yankee Atomic Electric Company. Dr. Kadak's current interests, in addition to nuclear space power, are the development of innovative new nuclear power plants such as the pebble bed reactor and improved management systems for existing and future nuclear power stations.

From 1989 to 2000, he was director of science communications at the Science Museum in London, one of the oldest and largest museums of science and technology in the world. Appointed in 1989 by Imperial College, London, to the first professorship of Public Understanding of Science, he devoted the next 11 years to galvanizing the new field nationally and internationally, and also founded the first peer-reviewed international academic journal devoted to research in the public dimensions of science and technology. Most recently, as chief executive officer of At-Bristol, he helped establish the independent, not-for-profit science and natural history center as the largest science-based visitor attraction in the U.K. outside London. As a member of the House of Lords Select Committee of Science and Technology from 1999-2000, Durant assisted in the drafting and editing of one of the most influential and widely cited policy documents on science and society in Europe.

As the Biotechnology Markets Leader, Scott is responsible for all aspects of Ernst & Young's global marketing, communication and go-to-market strategies for the biotechnology industry. In this role, Mr. Sarazen and his team serve as the primary conduit between the firm and the biotechnology and medical device industries for the purposes of identifying and tracking the changing landscape of these dynamic sectors. The Markets Leader also oversees thought leadership, including the production of Beyond Borders, Ernst & Young's annual report on the biotechnology industry. Scott is resident at Ernst & Young's Global Biotechnology Center based in Boston. Prior to joining Ernst & Young, Mr. Sarazen has enjoyed over 18 years of experience supporting strategic operations and business development in the biotechnology and biomedical industries in roles including: Senior Vice President of Corporate Development at Straumann, North America and Director of Global Planning and Development at Genzyme Corporation. Scott has also served in public roles as both the Senior Vice President for Life Sciences with MassDevelopment and as a special consultant to the Chief Economic Development Officer of the City of Boston for the purposes of advocating the expansion of the biomedical economies in Massachusetts. Mr. Sarazen has a BS in Engineering from Worcester Polytechnic Institute and a MS in Management from Lesley University.

Heuser serves as the deputy editor for the Ideas section, which appears weekly in the Boston Sunday Globe. Ideas features colorful reporting and probing commentary on the ideas, people, books and trends that are shaking up the intellectual world. Prior to his current role, specialized in coverage of biotechnology -- including the business of life science, medical devices, nanotechnology and pharmaceuticals in the New England region -- for the Boston Globe business section. He has been member of the paper's editorial staff since 2001. [Source: http://www.bostonglobe.com/news/resources/bio.aspx?id=3956]

Oliver Peoples is a co-founder of Metabolix, a company which delivers sustainable solutions for the world's need in plastics, chemicals, and energy. He has served as Chief Scientific Officer and Vice President of Research and Development since January of 2000, and was previously Director of Research and Vice President. Before founding Metabolix, Peoples was a research scientist with the Department of Biology at the MIT where he was a pioneer of the new field of metabolic pathway engineering and its applications in industrial biotechnology.